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We have previously described the reconstitution, in a cell-free system, of the constitutive delivery of a newly synthesized protein, influenza neurami- 
nidase, to the plasma membrane in BHK cells. Here we report some of the characteristics of this in vitro membrane fusion event. We show that 
fusion requires ATP hydrolysis, and exploit this requirement to ~stin~sh the time-course of fusion from that of neuraminidase action. In addition, 
we present evidence for the occurrence of multiple fusions between hybrid membrane vesicles. 
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1. INTRODUCTION 
It has been pointed out many times that the molecular 
basis of intracellul~ protein transport will become ac- 
cessible to biochemical analysis only when the various 
transport steps have been reconstituted in cell-free 
systems [l]. To this end, cell-free assays have been 
developed for many of the major transport steps, in- 
cluding endoplasmic reticulum-to-c& Golgi [2] and 
intra-Golgi [3,4] transport, constitutive [S] and 
regulated [6-g] delivery to the plasma membrane, and 
membrane fusion events on the endocytic pathway 
[9-131. These assays are now being used to elucidate the 
molecular details of intracellular protein transport [l]. 
We have previously reported the reconstitution, in a 
cell-free system, of the insertion of a newly synthesized 
protein into the plasma membrane of BHK cells [S] . In 
this system, membrane vesicles containing influenza 
neuraminidase, initially present in a ‘donor’ post- 
nuclear supernatant, fuse with vesiculated plasma mem- 
branes from an ‘acceptor’ post-nuclear supernatant. 
Fusion is monitored through the ability of neuramini- 
dase to cleave 3H-labelled sialic acid residues from the 
envelope proteins of Semliki Forest virus (SFV) par- 
ticles, that are bound to the outside surface of the 
plasma membrane before vesiculation. A membrane fu- 
sion event occurs that is dependent on the presence of 
ATP, that is specific (in that fusion activity is maximal 
when neuraminidase is concentrated at a late stage in 
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the exocytic transport pathway) and that is abolished by 
proteolytic treatment of the cell extracts. This paper 
describes a further characterization of this in vitro 
membrane fusion event. 
2. MATERIALS AND METHODS 
The sources of all cells, viruses and chemicals, the preparation of 
donor and acceptor post-nuclear supernatants and the procedure for 
the cell-free assay were as described previously [S], with the following 
two modifications: the buffer solution used in the preparation of the 
post-nuclear supernatants was 10 mM Tris-HCl, pH 7.5, 1 mM 
magnesium acetate (i.e. no sucrose was added) and a cocktail of pro- 
tease inhibitors (benzamidine 17 yg/ml, pepstatin, 1 pg/ml, phenyl- 
methylsulphonylfluoride 1 mM, antipain 1 p&/ml, soybean trypsin in- 
hibitor 10 fig/ml and bacitracin 50 /cg/ml) was added to all incuba- 
tions. ATP-generating cocktails contained, as before (final eoncentra- 
tions) ATP 1 mM, creatine phosphate 8 mM, creatine phosphokinase 
7 IU/ml; ATP-depleting cocktails contained (final concentrations) 
hexokinase 25 NJ/ml, glucose 5 mM. Typically, about 50 fig of both 
donor and acceptor membrane protein and 5Opg cytosolic protein was 
added to an incubation volume of 250~1. Radioactivity in acceptor 
preparations was about 5000 dpm sample. 
3. RESULTS AND DISCUSSION 
Membrane fusion in the cell-free system has been 
shown to depend on the presence of ATP [5]. In was not 
clear, however, whether ATP hydrolysis was required. 
To answer this question, the ability of a non-hydro- 
lysable analogue of ATP, 5 ’ -adenylylimidodiphos- 
phate (AMP-PNP), to support fusion was tested. Nor- 
mal incubations, with ATP-generating and ATP- 
depleting cocktails, were carried out, together with a 
third incubation in which AMP-PNP was added to a 
sample that had been depleted of ATP, Table I shows 
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Tabie 1 
Test of the ability of AMP-PNP to support membrane fusion 
Experimental condition Release of [‘Hlsialic acid (Yo) 
blank donor - ATP + AMP-PNP 
blank donor + ATP 
0.0 f 0.4 
0.0 + 0.4 
donor - ATP + AMP-PNP 
donor + ATP 
0.0 * 0.4 
1.5 f 0.6 
Donor (or blank donor) and acceptor post-nuclear supernatants were 
incubated together for 2 h at 37°C in the presence or absence of ATP. 
At the end of the incubation, protein was precipitated by addition of 
10% trichloroacetic acid followed by centrifugation, and the 
[‘H]sialic acid present in the supernatant determined. AMP-PNP (1 
mM) was added to some ATP-depleted samples. Release of [‘Hlsialic 
acid, expressed as a percentage of the total present in the sample, is 
corrected for the background release obtained in the absence of ATP. 
Values are means f SE from two separate xperiments (n = 6). 
the values for release of [3H]sialic acid given by both a 
blank donor (prepared from uninfected cells) and a 
neuraminidase-containing donor. It is apparent that 
while ATP supported a neuraminidase-dependent 
release of [3H]sialic acid above background, AMP- 
PNP did not. This result indicates that hydrolysis of 
ATP is required to drive membrane fusion in this cell- 
free system. It has been shown [5] that latent [3H]SFV 
(i.e. that present in sealed ‘inside-out’ plasma mem- 
brane vesicles) typically represents 16% of the total, 
and that the maximum possible cleavage of [3H]sialic 
acid from free [3H]SFV by neuraminidase is 60%. 
Hence, if all of the [3H]SFV present within sealed 
‘inside-out’ vesicles becomes exposed to neuraminidase, 
approximately 10% of the total [3H]sialic acid will be 
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Fig. 1. Time-course of fusion. Samples of acceptor were incubated 
with either donor (m) or blank donor (+) for various times in the 
presence of ATP. An ATP-depleting cocktail was then added and in- 
cubation continued for a further 60 min. Values are means f SE of 
triplicate determinations and are corrected for [“Hlsialic acid release 
Fig. 2. Dependence of [‘Hlsialic acid release on donor concentration. 
Samples of acceptor (25 ,~l) were incubated for 2 h at 37°C with 
various volumes of donor(n) or blank donor (e). (A) ATP-dependent 
release of [3H]sialic acid. (B) ATP-independent release given by 
donor, corrected for release occurring with blank donor. Values are 
occurring in the absence of ATP. means f SE of triplicate determinations. 
released. The 1.5% release of [3H]sialic acid shown in 
Table I, therefore, indicates that 15% of the acceptor 
vesicles have fused with donor vesicles. 
The time-course of ATP-dependent release of 
[3H]sialic acid is sigmoid, with a maximum rate of 
release at 30 min and saturation at about 60 min [5]. 
The most resonable interpretation of this result is that 
delivery of neuraminidase to its substrate is complete 
after 30 min (the point at which the rate of product 
release peaks) and that the enzyme-substrate interaction 
then continues to completion over the next 30 min. In 
order to test this idea, it was necessary to devise a 
method for measuring membrane fusion itself. The 
method chosen exploits the fact that fusion requires 
ATP whereas neuraminidase activity does not. Samples 
were incubated initially in the presence of an ATP- 
generating cocktail. At various times, an ATP-deple- 
ting cocktail was added and the incubation continued 
for a further 60 min to allow enzyme-substrate inter- 
action to proceed to completion. The time-course of the 
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ATP-dependence of release of [‘Hlsialic acid generated 
in this way is shown in Fig. 1. This time-course, which 
represents the time-course of fusion, has a 10 min lag 
phase and then a rising phase of half-time approximate- 
ly 10 min. Fusion is almost over after 30 min, when the 
rate of [‘Hlsialic acid release in the earlier time-course 
[5] is maximal. 
The relationship between donor vesicle concentration 
and [‘Hlsialic acid release was investigated, in order to 
determine whether or not multiple fusion events be- 
tween hybrid vesicles occur in the cell-free system. The 
fact that release of cleavable, latent [3H]sialic acid is of 
the order of lo-20% at the normal donor :acceptor 
concentration ratio of 1: 1 suggests that the number of 
fusion-competent donor vesicles in a typical incubation 
is limiting. If only single fusion events occur, then at a 
ratio of 1: 1, half of the donor vesicles will fuse with 
labelled acceptor vesicles and half with ‘blank’ acceptor 
vesicles present in the donor post-nuclear supernatant. 
Now if the ratio is increased to 2: 1, only one-third of 
the donor vesicles will fuse with labelled acceptor 
vesicles. However, since there are now twice as many 
donor vesicles the delivery of neuraminidase to latent 
[3H]SFV will increase, maximally, by a factor of 1.33. 
For a concentration ratio of 4: 1 this factor will be 1.6, 
and as the concentration ratio tends to infinity, it will 
tend to become 2-fold. Another effect of increasing the 
donor : acceptor ratio will be to increase the proportion 
of the labelled acceptor vesicles that fuse with active 
donor vesicles, rather than with ‘blank’ donor vesicles 
present in the acceptor post-nulear supernatant. Since 
only a small proportion (lo-20%) of the acceptor 
vesicles fuse with either active or blank donor vesicles 
initially, however, the contribution of this effect to the 
predicted increase in the ATP-dependent release of 
[3H]sialic acid will be small. If fusion between hybrid 
vesicles is permitted, the ATP-dependent release of 
[3H]sialic acid should tend towards the maximum value 
of 10% as the donor : acceptor concentration ratio rises. 
In both cases the ATP-independent release, which is ap- 
parently a consequence of residual extravesicular 
neuraminidase activity and not related to fusion [5], 
should rise linearly with concentration ratio. In the ex- 
periment illustrated in Fig. 2, the donor : acceptor ratio 
was increased from 1: 1 to 4 : 1 and ATP-dependent and 
independent release of t3H]sialic acid was measured. It 
can be seen that the ATP-dependent release of 
[3H]sialic acid increased from 0.6% at a ratio of 1: 1 to 
4.4% at a ratio of 4: 1, a rise of more than 7-fold. This 
result indicates that multiple fusions occur, as has 
recently been reported for an in vitro fusion event oc- 
curring on the endocytic pathway [13], and that at high 
donor : acceptor ratios neuraminidase gains access to 
about half of the latent [3H]SFV. ATP-independent 
release rises approximately linearly from 3.2% to 8.7%, 
as expected. 
Acknowledgement: We thank the Medical Research Council for 
financial support. 
REFERENCES 
[l] Batch, W.E. (1989) J. Biol. Chem. 264, 16965-16968. 
[2] Balch, W.E., Wagner, K.R. and Keller, D.S. (1987) J. Cell Biol. 
104, 749-760. 
[3] Balch, W.E., Dunphy, W.G., Braell, W.E. and Rothman, J.E. 
(1984) Cell 39, 405-416. 
[4] Rothman, J.E. (1987) J. Biol. Chem. 262, 12502-12510. 
[5] Woodman, P.G. and Edwardson, J.M. (1986) J. Cell Biol. 103, 
1829-1835. 
[6] Whitaker, M.J. and Baker, P.F. (1983) Proc. Roy. Sot. Lond. 
Ser. B 218, 397-413. 
[7] Crabb, J.H. and Jackson, R.C. (1985) J. Cell Biol. 101, 
2263-2273. 
[8] Nadin, C.Y., Rogers, J., Tomlinson, S. and Edwardson, J.M. 
(1989) J. Cell Biol. 109, 2801-2808. 
[9] Gruenberg, J.E. and Howell, K.E. (1986) EMBO J. 5, 
3091-3101. 
[lo] Braell, W.A. (1987) Proc. Natl. Acad. Sci. USA 84, 1137-1141. 
[ll] Woodman, P.G. and Warren, G. (1988) Eur. J. Biochem. 173, 
101-108. 
[12] Diaz, R., Mayorga, L. and Stahl, P. (1988) J. Biol. Chem. 263, 
6093-6100. 
[13] Wessling-Resnick, M. and Braell, W.A. (1990) J. Biol. Chem. 
265, 690-699. 
109 
